Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Heath, James R"'
Autor:
Lu Y; Institute for Systems Biology, Seattle, WA, USA., Ng AHC; Institute for Systems Biology, Seattle, WA, USA., Chow FE; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Everson RG; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Helmink BA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thakur R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cloughesy TF; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Prins RM; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Heath JR; Institute for Systems Biology, Seattle, WA, USA. jim.heath@isbscience.org.
Publikováno v:
Nature communications [Nat Commun] 2021 Jun 29; Vol. 12 (1), pp. 4031. Date of Electronic Publication: 2021 Jun 29.
Autor:
Chuntova P; Department of Neurological Surgery, UCSF, San Francisco, California., Chow F; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California., Watchmaker PB; Department of Neurological Surgery, UCSF, San Francisco, California., Galvez M; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, Los Angeles, California., Heimberger AB; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Newell EW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Diaz A; Department of Neurological Surgery, UCSF, San Francisco, California., DePinho RA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Li MO; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Wherry EJ; Department of Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Mitchell D; Department of Neurosurgery, University of Florida College of Medicine, Gainesville, Florida., Terabe M; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Wainwright DA; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Berzofsky JA; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Herold-Mende C; Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany., Heath JR; Institute for Systems Biology, Seattle, Washington., Lim M; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland., Margolin KA; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts., Kasahara N; Department of Neurological Surgery, UCSF, San Francisco, California., Ellingson BM; Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California., Brown CE; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, California., Chen Y; Department of Microbiology, Immunology & Molecular Genetics, UCLA, Los Angeles, California., Fecci PE; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina., Reardon DA; Department of Medicine/Medical Oncology, Harvard Medical School, Boston, Massachusetts., Dunn GP; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri., Liau LM; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California., Costello JF; Department of Neurological Surgery, UCSF, San Francisco, California., Wick W; Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany., Cloughesy T; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California., Timmer WC; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Prins RM; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, Los Angeles, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California., Platten M; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany.; DKTK CCU Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Okada H; Department of Neurological Surgery, UCSF, San Francisco, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2021 Mar 25; Vol. 23 (3), pp. 356-375.
Autor:
Wen PY; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Touat M; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Alexander BM; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Mellinghoff IK; 3 Memorial Sloan Kettering Cancer Center, New York, NY., Ramkissoon S; 1 Dana-Farber Cancer Institute, Boston, MA., McCluskey CS; 1 Dana-Farber Cancer Institute, Boston, MA., Pelton K; 1 Dana-Farber Cancer Institute, Boston, MA., Haidar S; 1 Dana-Farber Cancer Institute, Boston, MA., Basu SS; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Gaffey SC; 1 Dana-Farber Cancer Institute, Boston, MA., Brown LE; 1 Dana-Farber Cancer Institute, Boston, MA., Martinez-Ledesma JE; 4 The University of Texas M.D. Anderson Cancer Center, Houston, TX., Wu S; 4 The University of Texas M.D. Anderson Cancer Center, Houston, TX., Kim J; 5 California Institute of Technology, Pasadena, CA., Wei W; 6 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA.; 10 Institute for Systems Biology, Seattle, WA., Park MA; 1 Dana-Farber Cancer Institute, Boston, MA., Huse JT; 4 The University of Texas M.D. Anderson Cancer Center, Houston, TX., Kuhn JG; 7 The University of Texas, San Antonio, San Antonio, TX., Rinne ML; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Colman H; 8 Huntsman Cancer Institute and University of Utah, Salt Lake City, UT., Agar NYR; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Omuro AM; 3 Memorial Sloan Kettering Cancer Center, New York, NY., DeAngelis LM; 3 Memorial Sloan Kettering Cancer Center, New York, NY., Gilbert MR; 4 The University of Texas M.D. Anderson Cancer Center, Houston, TX., de Groot JF; 4 The University of Texas M.D. Anderson Cancer Center, Houston, TX., Cloughesy TF; 6 David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA., Chi AS; 9 New York University School of Medicine, New York, NY., Roberts TM; 1 Dana-Farber Cancer Institute, Boston, MA., Zhao JJ; 1 Dana-Farber Cancer Institute, Boston, MA., Lee EQ; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Nayak L; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Heath JR; 10 Institute for Systems Biology, Seattle, WA., Horky LL; 1 Dana-Farber Cancer Institute, Boston, MA., Batchelor TT; 11 Massachusetts General Hospital, Boston, MA., Beroukhim R; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Chang SM; 12 University of California, San Francisco, San Francisco, CA., Ligon AH; 2 Brigham and Women's Hospital, Boston, MA., Dunn IF; 2 Brigham and Women's Hospital, Boston, MA., Koul D; 4 The University of Texas M.D. Anderson Cancer Center, Houston, TX., Young GS; 2 Brigham and Women's Hospital, Boston, MA., Prados MD; 12 University of California, San Francisco, San Francisco, CA., Reardon DA; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA., Yung WKA; 4 The University of Texas M.D. Anderson Cancer Center, Houston, TX., Ligon KL; 1 Dana-Farber Cancer Institute, Boston, MA.; 2 Brigham and Women's Hospital, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Mar 20; Vol. 37 (9), pp. 741-750. Date of Electronic Publication: 2019 Feb 04.
Autor:
Kravchenko-Balasha N; NanoSystems Biology Cancer Center, Division of Chemistry, Caltech , Pasadena, California 91125, United States.; Bio-Medical Sciences Department, The Faculty of Dental Medicine, The Hebrew University of Jerusalem , Jerusalem 9112001, Israel., Johnson H; Signaling Programme, The Babraham Institute , Cambridge CB22 3AT, United Kingdom., White FM; Department of Biological Engineering, MIT , Cambridge, Massachusetts 02139, United States., Heath JR; NanoSystems Biology Cancer Center, Division of Chemistry, Caltech , Pasadena, California 91125, United States., Levine RD; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine and Department of Chemistry and Biochemistry, UCLA , Los Angeles, California 90095, United States.; The Institute of Chemistry, The Hebrew University of Jerusalem , Jerusalem 91904, Israel.
Publikováno v:
The journal of physical chemistry. B [J Phys Chem B] 2016 Jul 07; Vol. 120 (26), pp. 5990-7. Date of Electronic Publication: 2016 Apr 12.
Autor:
Wei W; Division of Chemistry and Chemical Engineering, NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125, USA; Department of Applied Physics and Materials Science, California Institute of Technology, Pasadena, CA 91125, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA., Shin YS; Division of Chemistry and Chemical Engineering, NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA., Xue M; Division of Chemistry and Chemical Engineering, NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125, USA., Matsutani T; Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA., Masui K; Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA., Yang H; Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA., Ikegami S; Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA., Gu Y; Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA., Herrmann K; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA., Johnson D; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA., Ding X; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Hwang K; Division of Chemistry and Chemical Engineering, NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125, USA., Kim J; Division of Chemistry and Chemical Engineering, NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125, USA., Zhou J; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Su Y; Division of Chemistry and Chemical Engineering, NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125, USA., Li X; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Bonetti B; Department of Neurological and Movement Sciences, University of Verona, Verona, 37134, Italy., Chopra R; Celgene Corporation, San Diego, CA 92121, USA., James CD; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA., Cavenee WK; Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA., Cloughesy TF; Department of Neurology, University of California, Los Angeles, Los Angeles, CA 90095, USA., Mischel PS; Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: pmischel@ucsd.edu., Heath JR; Division of Chemistry and Chemical Engineering, NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: heath@caltech.edu., Gini B; Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA 92093, USA.
Publikováno v:
Cancer cell [Cancer Cell] 2016 Apr 11; Vol. 29 (4), pp. 563-573.
Autor:
Xue M; Division of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States., Wei W; Department of Molecular and Medical Pharmacology, University of California , Los Angeles, California 90095, United States., Su Y; Division of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States., Johnson D; Department of Molecular and Medical Pharmacology, University of California , Los Angeles, California 90095, United States., Heath JR; Division of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.; Department of Molecular and Medical Pharmacology, University of California , Los Angeles, California 90095, United States.
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 2016 Mar 09; Vol. 138 (9), pp. 3085-93. Date of Electronic Publication: 2016 Feb 26.
Autor:
Kravchenko-Balasha N; NanoSystems Biology Cancer Center, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125., Wang J, Remacle F, Levine RD, Heath JR
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2014 Apr 29; Vol. 111 (17), pp. 6521-6. Date of Electronic Publication: 2014 Apr 14.
Autor:
Wang J; NanoSystems Biology Cancer Center and Kavli Nanoscience Institute, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States., Tham D, Wei W, Shin YS, Ma C, Ahmad H, Shi Q, Yu J, Levine RD, Heath JR
Publikováno v:
Nano letters [Nano Lett] 2012 Dec 12; Vol. 12 (12), pp. 6101-6. Date of Electronic Publication: 2012 Nov 07.